Published reports suggest that pioglitazone and rosiglitazone have different effects on lipids in patients with type 2 diabetes. However, these previous studies were either retrospective chart ...

This is a useful study that seeks to address the role of the TET family of DNA demethylation enzymes in pancreatic beta cell senescence in the context of type 2 diabetes (T2DM). Although the concepts ...

“Oh, God,” purred the Iranian, “I’m so happy to have some people!” We paused our frantic cross-table whispering as a member ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications ...

Breakthrough research into diabetes medications and stroke prevention Recent groundbreaking research has raised the possibility of a game-changing approach to stroke prevention. A study analyzing ...

LOS ANGELES - A new clinical trial in The BMJ found that combining calorie restriction with the diabetes drug dapagliflozin reversed type 2 diabetes in nearly half of participants. The approach ...

However, the study also found that certain diabetes medications like pioglitazone, antipsychotic prescriptions and benzodiazepines, which are generally used to treat anxiety, insomnia and seizures ...

In most cases, your doctor will start by prescribing oral medication. Metformin is the first-line treatment for the majority of people with type 2 diabetes. Over time, you might need to add other ...

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy, further complicating big decisions the Trump ...